Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Operations (Unaudited)

v3.8.0.1
Consolidated Statements of Operations and Comprehensive Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Oct. 01, 2016
Sep. 30, 2017
Oct. 01, 2016
Income Statement [Abstract]        
Net sales $ 73,807 $ 73,452 $ 234,848 $ 232,197
Cost of sales [1] 51,930 51,081 165,940 161,593
Gross profit 21,877 22,371 68,908 70,604
Operating expenses:        
Marketing 9,476 10,158 30,038 31,376
General and administrative 4,275 4,350 13,386 13,323
Fulfillment 5,584 5,596 17,595 17,292
Technology 1,163 1,517 3,572 4,158
Amortization of intangible assets 47 111 271 336
Total operating expenses 20,545 21,732 64,862 66,485
Income from operations 1,332 639 4,046 4,119
Other income (expense):        
Other income, net 15 8 50 25
Interest expense (400) (291) (1,247) (889)
Total other expense, net (385) (283) (1,197) (864)
Income from continuing operations before income taxes 947 356 2,849 3,255
Income tax (benefit) provision 28 (2) (25,804) 87
Income from continuing operations 919 358 28,653 3,168
Discontinued operations        
Loss from operations and disposal of discontinued AutoMD operations [2] 0 (723) (558) (2,156)
Income tax (benefit) provision [2] 0 (5) 1 (299)
Loss on discontinued operations [2] 0 (718) (559) (1,857)
Net income (loss) 919 (360) 28,094 1,311
Other comprehensive income (loss):        
Foreign currency translation adjustments 9 (16) 6 (29)
Total other comprehensive income (loss) 9 (16) 6 (29)
Comprehensive income (loss) $ 928 $ (376) $ 28,100 $ 1,282
Income from continuing operations per share:        
Basic income from continuing operations per share (in USD per share) $ 0.02 $ 0.01 $ 0.81 $ 0.09
Diluted income from continuing operations per share (in USD per share) $ 0.02 $ 0.01 $ 0.72 $ 0.07
Weighted average common shares outstanding:        
Shares used in computation of basic income from continuing operations per share (in shares) 35,856 34,932 35,233 34,728
Shares used in computation of diluted income from continuing operations per share (in shares) 39,485 40,591 39,858 40,076
[1] Excludes depreciation and amortization expense which is included in marketing, general and administrative and fulfillment expense.
[2] During March 2017, AutoMD filed for dissolution and the AutoMD operating segment has been classified as discontinued operations.